Compounds > alovudine
Page last updated: 2024-08-23

alovudine and Adenocarcinoma, Basal Cell

alovudine has been researched along with Adenocarcinoma, Basal Cell in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (50.00)29.6817
2010's6 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jiang, HJ; Li, M; Li, X; Pan, WB; Wang, YQ; Xu, HL; Zhang, MY; Zhang, RJ1
Bradshaw, TJ; Forrest, LJ; Jallow, N; Jeraj, R; Yip, S1
Dahlman, A; Fröhlich, C; Horak, ID; Jacobsen, HJ; Jensen, MM; Kjaer, A; Kragh, M; Kristensen, LK; Lantto, J; Nielsen, CH; Poulsen, TT1
Haba, R; Hagiike, M; Izuishi, K; Kaji, M; Kameyama, R; Murota, M; Nishiyama, Y; Takebayashi, R; Yamamoto, Y1
Krause, BJ; Lordick, F; Ott, K1
Dietlein, M; Kahraman, D; Kobe, C; Neumaier, B; Nogova, L; Scheffler, M; Thomas, R; Wolf, J; Zander, T1
Asher, C; Chu, SK; Garwin, GG; Johnson, BW; Krohn, KA; Li, T; Miyaoka, RS; Plotnik, DA; Schwartz, JL1
Grierson, JR; Kolb, PD; Rasey, JS; Schwartz, JL; Wiens, LW1
Grierson, JR; Jordan, R; Krohn, KA; Schwartz, JL; Tamura, Y1
Grierson, JR; Jordan, R; Krohn, KA; Muzi, M; Schwartz, JL1
Binns, D; Conus, N; Cullinane, C; Dorow, DS; Hicks, RJ; McArthur, GA; McCarthy, TJ; Roselt, P1
Chang, ST; Chin, F; Dick, DW; Gambhir, SS; Kamaya, A; Koong, AC; Loo, BW; Quon, A1

Reviews

1 review(s) available for alovudine and Adenocarcinoma, Basal Cell

ArticleYear
[Positron emission tomography - current role in the diagnosis and treatment of upper gastrointestinal carcinomas].
    Deutsche medizinische Wochenschrift (1946), 2011, Volume: 136, Issue:20

    Topics: Adenocarcinoma; Combined Modality Therapy; Dideoxynucleosides; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Sensitivity and Specificity; Stomach Neoplasms; Tomography, X-Ray Computed; Treatment Outcome

2011

Other Studies

11 other study(ies) available for alovudine and Adenocarcinoma, Basal Cell

ArticleYear
Prediction of tumor biological characteristics in different colorectal cancer liver metastasis animal models using
    Hepatobiliary & pancreatic diseases international : HBPD INT, 2018, Volume: 17, Issue:2

    Topics: Adenocarcinoma; Animals; Cell Line, Tumor; Colorectal Neoplasms; Dideoxynucleosides; Feasibility Studies; Fluorodeoxyglucose F18; Humans; Hyaluronan Receptors; Immunohistochemistry; Ki-67 Antigen; Linear Models; Liver Neoplasms; Mice, Nude; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Time Factors; Vascular Endothelial Growth Factor A

2018
Spatiotemporal stability of Cu-ATSM and FLT positron emission tomography distributions during radiation therapy.
    International journal of radiation oncology, biology, physics, 2014, Jun-01, Volume: 89, Issue:2

    Topics: Adenocarcinoma; Animals; Carcinoma, Squamous Cell; Cell Hypoxia; Cell Proliferation; Chondrosarcoma; Coordination Complexes; Dideoxynucleosides; Dog Diseases; Dogs; Dose Fractionation, Radiation; Multimodal Imaging; Nose Neoplasms; Organometallic Compounds; Osteosarcoma; Paranasal Sinus Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Intensity-Modulated; Thiosemicarbazones; Tomography, X-Ray Computed

2014
In vivo imaging of therapy response to a novel pan-HER antibody mixture using FDG and FLT positron emission tomography.
    Oncotarget, 2015, Nov-10, Volume: 6, Issue:35

    Topics: Adenocarcinoma; Animals; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Proliferation; Dideoxynucleosides; ErbB Receptors; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Mice, Nude; Multimodal Imaging; Pancreatic Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Receptor, ErbB-2; Receptor, ErbB-3; Time Factors; Tumor Burden; X-Ray Microtomography; Xenograft Model Antitumor Assays

2015
Detection of gastric cancer using 18F-FLT PET: comparison with 18F-FDG PET.
    European journal of nuclear medicine and molecular imaging, 2009, Volume: 36, Issue:3

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Cell Proliferation; Dideoxynucleosides; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Ki-67 Antigen; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Stomach Neoplasms

2009
Monitoring reversible and irreversible EGFR inhibition with erlotinib and afatinib in a patient with EGFR-mutated non-small cell lung cancer (NSCLC) using sequential [18F]fluorothymidine (FLT-)PET.
    Lung cancer (Amsterdam, Netherlands), 2012, Volume: 77, Issue:3

    Topics: Adenocarcinoma; Afatinib; Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Dideoxynucleosides; DNA Mutational Analysis; Drug Resistance, Neoplasm; ErbB Receptors; Erlotinib Hydrochloride; Fatal Outcome; Female; Humans; Lung Neoplasms; Quinazolines; Radionuclide Imaging; Radiopharmaceuticals; Sequence Deletion

2012
Levels of human equilibrative nucleoside transporter-1 are higher in proliferating regions of A549 tumor cells grown as tumor xenografts in vivo.
    Nuclear medicine and biology, 2012, Volume: 39, Issue:8

    Topics: Adenocarcinoma; Adenocarcinoma of Lung; Animals; Biological Transport; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Dideoxynucleosides; Equilibrative Nucleoside Transporter 1; Humans; Lung Neoplasms; Male; Mice; Positron-Emission Tomography; Protein Transport

2012
Validation of FLT uptake as a measure of thymidine kinase-1 activity in A549 carcinoma cells.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2002, Volume: 43, Issue:9

    Topics: Adenocarcinoma; Cell Cycle; Cell Division; Culture Media; Dideoxynucleosides; Fluorine Radioisotopes; Humans; Lung Neoplasms; Thymidine Kinase; Tumor Cells, Cultured

2002
Effect of p53 activation on cell growth, thymidine kinase-1 activity, and 3'-deoxy-3'fluorothymidine uptake.
    Nuclear medicine and biology, 2004, Volume: 31, Issue:4

    Topics: Adenocarcinoma; Cell Division; Cell Line, Tumor; Dideoxynucleosides; Dose-Response Relationship, Radiation; Enzyme Activation; Gamma Rays; Humans; Lung Neoplasms; Thymidine Kinase; Tumor Suppressor Protein p53

2004
Metabolism of 3'-deoxy-3'-[F-18]fluorothymidine in proliferating A549 cells: validations for positron emission tomography.
    Nuclear medicine and biology, 2004, Volume: 31, Issue:7

    Topics: Adenocarcinoma; Cell Line, Tumor; Cell Proliferation; Dideoxynucleosides; Humans; Kinetics; Lung Neoplasms; Metabolic Clearance Rate; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals

2004
Multi-tracer small animal PET imaging of the tumour response to the novel pan-Erb-B inhibitor CI-1033.
    European journal of nuclear medicine and molecular imaging, 2006, Volume: 33, Issue:4

    Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Dideoxynucleosides; ErbB Receptors; Fluorodeoxyglucose F18; Humans; Mice; Morpholines; Positron-Emission Tomography; Prognosis; Protein-Tyrosine Kinases; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome; Tumor Cells, Cultured

2006
Initial evaluation of 18F-fluorothymidine (FLT) PET/CT scanning for primary pancreatic cancer.
    European journal of nuclear medicine and molecular imaging, 2008, Volume: 35, Issue:3

    Topics: Adenocarcinoma; Aged; Aged, 80 and over; Dideoxynucleosides; Female; Humans; Male; Middle Aged; Pancreatic Neoplasms; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed

2008